Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults  Alexander A. Leung, MD, MPH,

Slides:



Advertisements
Similar presentations
2001 Canadian Hypertension Education Program Recommendations 1 Focus on the 2001 Canadian Recommendations for the Management of Hypertension Version: April.
Advertisements

Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
2007 Methodology used for the production of the Canadian.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
Process for Guideline Development in Canada 2011 Canadian Hypertension Education Program Recommendations.
2015 Canadian Hypertension Education Program Recommendations
Section VII. Home BP Measurement 2015 Canadian Hypertension Education Program Recommendations.
Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,
Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.
Systemic Implementation Strategies to Improve Hypertension: The Kaiser Permanente Southern California Experience  John J. Sim, MD, Joel Handler, MD, Steven.
Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 
Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,
Thomas G. Pickering, MD, DPhil, William B. White, MD 
Ambulatory Blood Pressure Monitoring in Clinical Practice: A Review
Eoin O’Brien, DSc, MD, Eamon Dolan, MD, FRCPI  Clinical Therapeutics 
Sex differences in health behavior change after premature acute coronary syndrome  Sylvie S.L. Leung Yinko, RD, MSc, Janane Maheswaran, BSc, Roxanne Pelletier,
The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment.
The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment.
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice  Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,
The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment.
904 Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga: Results From a Randomized Controlled Trial  K. Blom, B. Baker, M.
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.
Aspirin Use Among U.S. Adults
The Demise of Morphine Oxygen Nitroglycerin Aspirin (MONA)
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy 
Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children  Kara A. Nerenberg,
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult  Todd J.
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice  Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,
Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy  Sonia Butalia, BSc, MD, MSc, Francois Audibert, MD, MSc, Anne-Marie.
The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure  Robert S. McKelvie, MD,
Clinical prediction rule to determine the need for repeat ERCP after endoscopic treatment of postsurgical bile leaks  Apostolos V. Tsolakis, MD, PhD,
Sandra Lauck, RN, PhD, Dion Stub, MD, PhD, John Webb, MD 
Postoperative Remote Automated Monitoring: Need for and State of the Science  Michael H. McGillion, RN, PhD, Emmanuelle Duceppe, MD, FRCPC, PhD(c), Katherine.
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention,
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications 
Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection.
Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines  Paul F. Kantor, MBBCh, Jane.
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary  Terry A. Jacobson, MD, Matthew.
Health Care Use and Associated Time and Out of Pocket Expenditures for Patients With Cardiovascular Disease in a Publicly Funded Health Care System  Saba.
The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment.
Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes  Amer M.
Canadian Association of Radiologists Consensus Guidelines for the Prevention of Contrast-Induced Nephropathy: Update 2012  Richard J. Owen, MBBCh, MRCP,
Amy C. Arnold, PhD, MSCI, Satish R. Raj, MD, MSCI 
The Urinary Protein-to-Creatinine Ratio in Canadian Women at Risk of Preeclampsia: Does the Time of Day of Testing Matter?  Annie Lamontagne, MD, Anne-Marie.
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy 
Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery  A. Ahsan Ejaz, MD, Tomas D.
Dynamic QT Interval Changes from Supine to Standing in Healthy Children  Audrey Dionne, MD, Anne Fournier, MD, Nagib Dahdah, MD, Dominic Abrams, MD, Paul.
Andrew T. Yan, MD, Raymond T. Yan, MD, Mary Tan, BSc, Daniel G
The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment.
Recommendations From a National Panel on Quality Improvement in Obstetrics  Guylaine Lefebvre, MD, Lisa A Calder, MD, MSc, Ria De Gorter, BSc, Cara L Bowman,
The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of.
The Ross procedure: Time to reevaluate the guidelines
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults  Alexander A. Leung, MD, MPH,
The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment.
Volume 1, Issue 2, Pages (March 2019)
A New Algorithm for the Diagnosis of Hypertension in Canada
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.
The 2013 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment.
Subodh Verma, MD, PhD, Milan Gupta, MD, Paul M. Ridker, MD 
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 1: Non-ST–Segment.
The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization 
J. David Spence, BA, MBA, MD  Canadian Journal of Cardiology 
Mobile Medicine: Digital Dynamo or Virtual Vaporware
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary  Terry A. Jacobson, MD, Matthew.
Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?  D. George Wyse,
Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?  Jean-Eric Tarride, PhD, F. Russell Quinn,
Brian W. McCrindle, MD, MPH, Kevin C. Harris, MD 
Presentation transcript:

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults  Alexander A. Leung, MD, MPH, Stella S. Daskalopoulou, MD, PhD, Kaberi Dasgupta, MD, MSc, Kerry McBrien, MD, MPH, Sonia Butalia, BSc, MD, Kelly B. Zarnke, MD, MSc, Kara Nerenberg, MD, MSc, Kevin C. Harris, MD, MHSc, Meranda Nakhla, MD, MSc, Lyne Cloutier, RN, PhD, Mark Gelfer, MD, Maxime Lamarre-Cliche, MD, Alain Milot, MD, MSc, MD, Peter Bolli, MD, Guy Tremblay, MD, Donna McLean, RN, NP, PhD, Sheldon W. Tobe, MD, MSc(HPTE), Marcel Ruzicka, MD, PhD, Kevin D. Burns, MD, Michel Vallée, MD, PhD, G.V. Ramesh Prasad, MBBS, MSc, Steven E. Gryn, MD, Ross D. Feldman, MD, Peter Selby, MBBS, MHSc, Andrew Pipe, CM, MD, Ernesto L. Schiffrin, MD, PhD, Philip A. McFarlane, MD, PhD, Paul Oh, MD, Robert A. Hegele, MD, Milan Khara, MBChB, Thomas W. Wilson, MD, S. Brian Penner, MD, Ellen Burgess, MD, Praveena Sivapalan, MD, Robert J. Herman, MD, Simon L. Bacon, PhD, Simon W. Rabkin, MD, Richard E. Gilbert, MD, PhD, Tavis S. Campbell, PhD, Steven Grover, MD, MPA, George Honos, MD, Patrice Lindsay, RN, PhD, Michael D. Hill, MD, MSc, Shelagh B. Coutts, MD, Gord Gubitz, MD, Norman R.C. Campbell, MD, Gordon W. Moe, MD, MSc, Jonathan G. Howlett, MD, Jean-Martin Boulanger, MD, Ally Prebtani, MD, Gregory Kline, MD, Lawrence A. Leiter, MD, Charlotte Jones, MD, PhD, Anne-Marie Côté, MD, MHSc, Vincent Woo, MD, Janusz Kaczorowski, PhD, Luc Trudeau, MD, Ross T. Tsuyuki, BSc (Pharm), PharmD, MSc, Swapnil Hiremath, MD, MPH, Denis Drouin, MD, Kim L. Lavoie, PhD, Pavel Hamet, MD, PhD, Jean C. Grégoire, MD, Richard Lewanczuk, MD, PhD, George K. Dresser, MD, PhD, Mukul Sharma, MD, MSc, Debra Reid, PhD, DtP, Scott A. Lear, PhD, Gregory Moullec, PhD, Milan Gupta, MD, Laura A. Magee, MD, MSc, Alexander G. Logan, MD, Janis Dionne, MD, Anne Fournier, MD, Geneviève Benoit, MD, Janusz Feber, MD, Luc Poirier, BPharm, MSc, Raj S. Padwal, MD, MSc, Doreen M. Rabi, MD, MSc  Canadian Journal of Cardiology  Volume 33, Issue 5, Pages 557-576 (May 2017) DOI: 10.1016/j.cjca.2017.03.005 Copyright © 2017 Canadian Cardiovascular Society Terms and Conditions

Figure 1 Hypertension diagnostic algorithm. ABPM, ambulatory blood pressure measurement; AOBP, automated office blood pressure; BP, blood pressure. ∗If AOBP is used, use the mean calculated and displayed by the device. If non-AOBP (see †) is used, take at least 3 readings, discard the first, and calculate the mean of the remaining measurements. A history and physical exam should be performed and diagnostic tests ordered. †AOBP is performed with the patient unattended in a private area. Non-AOBP is performed using an electronic upper arm device with the provider in the room. ‡Diagnostic thresholds for AOBP, ABPM, and home BP in patients with diabetes have yet to be established (and might be lower than 13080 mm Hg). §Serial office measurements over 3-5 visits can be used if ABPM or home measurement is not available. ‖For a home BP series, 2 readings are taken each morning and evening for 7 days (28 total). Discard the first day readings and average the last 6 days. ¶Annual BP measurement is recommended to detect progression to hypertension. Canadian Journal of Cardiology 2017 33, 557-576DOI: (10.1016/j.cjca.2017.03.005) Copyright © 2017 Canadian Cardiovascular Society Terms and Conditions